DUBLIN--(BUSINESS WIRE)--The new research portal will provide visitors with unparalleled access to company research on Genentech, alongside comprehensive market research on their position within the global biotechnology industry.
Genentech engages in the research, development, manufacture, and marketing of biotechnology products for treating patients with serious or life-threatening diseases in the United States. It offers molecular entities and medicines in the areas of oncology, immunology, neuroscience, metabolism, and infectious diseases.
According to the World Biopharmaceuticals Market report, increasing regulatory approvals for biotechnology products is driving growth in the market. One such product is the recombinant DNA-based products, which has high rates of approval from regulatory authorities. The opportunities of this market are the ageing population and increase in the number of diseases. The challenges of this market are the reimbursement and pricing policy that are the limiting factors in the launch of high priced drugs.
“Genentech is a leading player within the biotechnology market and the new portal provides easy access to information on their performance as a company and their impact on the overall industry,” says Ross Glover, CEO of Research and Markets.
For more information visit: http://www.researchandmarkets.com/companies/genentech-inc?cid=fw3nd6
About Research and Markets
Research and Markets is the world's leading market research store.
With more than 1.5 million research resources, we deliver the largest collection of business information products on the market. We offer the most in-depth market analysis across a multitude of industries. Our products provide clients with an unrivalled understanding of their chosen market. No matter how specialist your field, we have the insights and market data to help you make efficient and effective decisions.